Table 2 Comparison of BMD pre- and post-ADT among men with advanced prostate cancer
From: Bone mineral density in Nigerian men on androgen deprivation therapy for advanced prostate cancer
Pre-ADT (N = 77) | 3-month post-ADT (N = 77) | p value | |
|---|---|---|---|
BMD T score | 0.001 | ||
Mean ± SD | − 0.78 ± 1.7 | − 1.15 ± 1.7 | |
Range | − 4.825, 3.069 | − 4.189, 3.509 | |
BMD group | |||
Normal (> − 1) | 43 (55.8) | 31 (40.3) | 0.043 |
Osteopenia (− 1 to − 2.5) | 23 (29.9) | 27 (35.1) | |
Osteoporosis (< − 2.5) | 11 (14.3) | 19 (24.7) | |
PSA | < 0.001 | ||
Median (Q1, Q3) | 345.9 (65.4, 1399.2) | 9.38 (1.6, 29.8) | |
Range | 17.0, 7865.0 | 1.6, 578.8 |